Core Viewpoint - Venus Concept Inc. has announced its decision to voluntarily delist from Nasdaq and cease SEC reporting due to compliance costs outweighing the benefits of remaining publicly listed [1][3]. Group 1: Delisting and SEC Reporting - The company plans to file a Form 25 with the SEC around January 30, 2026, with the last trading day on Nasdaq expected to be around February 6, 2026 [2]. - Following the delisting, Venus Concept will file a Form 15 on or about February 9, 2026, which will suspend its obligation to submit periodic SEC reports [2]. Group 2: Financial Position - As of September 30, 2025, the company's inventories were reported at $15.768 million, while cash and equivalents stood at $4.312 million [1]. Group 3: Company Overview - Venus Concept specializes in medical aesthetic technology, offering minimally invasive and non-invasive devices across more than 60 countries, including products like Venus NOVA, Venus Versa, and the ARTAS iX robotic hair restoration system [4]. - The company's stock price fell by 54.83% to $2.00, nearing its 52-week low of $1.39 [4].